Induction chemotherapy increases perioperative complications in patients undergoing resection for non–small cell lung cancer [PDF]
John R. Roberts+5 more
openalex +1 more source
Yi‐Fei‐Jie‐Du‐Tang (YFJDT), a traditional Chinese medicine, has shown potential in lung cancer treatment by targeting key pathways. This study explores the mechanisms of YFJDT using bioinformatics, xenograft models, and A549 cells, demonstrating that YFJDT downregulates HIF1A, promotes ferroptosis, and inhibits epithelial‐mesenchymal transition (EMT ...
Shanshan Wang+6 more
wiley +1 more source
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 [PDF]
Uy, Geoffrey L., Westervelt, Peter
core +1 more source
The role of induction chemotherapy in treatment of unresectable stage IV head and neck cancer.
Masatoshi Horiuchi+4 more
openalex +2 more sources
A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction [PDF]
Jaffer A. Ajani+13 more
openalex +1 more source
Gemcitabine and cisplatin induction chemotherapy followed by concurrent chemoradiotherapy for stage III-IVA nasopharyngeal carcinoma: A real-world study. [PDF]
Van DN, Viet SN, Phu GH.
europepmc +1 more source
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source
Comparison of ‘sequential’ versus ‘standard’ chemotherapy as re‐induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML‐R trial [PDF]
John A. Liu Yin+3 more
openalex +1 more source
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma. [PDF]
Huwyler F+4 more
europepmc +1 more source